Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8446756 | European Journal of Cancer | 2012 | 11 Pages |
Abstract
Further investigation is required to establish the real reasons for the lower survival in Eastern Europe. Considering the high prevalence of these highly curable cancers, it is important to monitor patients long-term, so as to quantify treatment-related risks and develop treatments having limited impact on quality of life.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
A. Trama, S. Mallone, N. Nicolai, A. Necchi, M. Schaapveld, J. Gietema, A. Znaor, E. Ardanaz, F. Berrino, The RARECARE working group The RARECARE working group,